OBJECTIVE: To explore the mediating role of the partner's dyadic coping in improving the stigma and quality of life (QOL) of the patient with premature ejaculation (PE). METHODS: We selected 480 PE patients seeking medical care in the clinic of urology and andrology from January to June 2023 by convenience sampling. Using a General Information Questionnaire, Dyadic Coping Inventory, Social Impact Scale, and Short-Form 12 Quality of Life Scale, we conducted an investigation among the patients and analyzed the mediation effect of the partner's dyadic coping on the patients' stigma and QOL. RESULTS: The mean scores on the partner's dyadic coping and the patients' stigma and QOL were (68.58±14.96), (47.67±30.13) and (90.18±28.93), respectively, with a significant correlation between the partner's dyadic coping and the patients' stigma and QOL (P<0.01). And the partner's dyadic coping was found to have an evident mediating role in improving the stigma and QOL of the patients, with a mediation effect of 36.38% of the total effect. CONCLUSION The QOL of the PE patients is at a below-average level, and the partner's dyadic coping plays a mediating role in improving the stigma and QOL of the patients. Design of dyadic coping-related intervention plans is recommended to improve the partner's dyadic coping, reduce the stigma of the patients and increase their QOL.
Humans ; Quality of Life ; Male ; Adaptation, Psychological ; Premature Ejaculation/psychology* ; Surveys and Questionnaires ; Sexual Partners/psychology* ; Social Stigma ; Adult ; Middle Aged

The aim of the study was to evaluate the long-term outcomes of pelvic floor muscle (PFM) rehabilitation in males with lifelong premature ejaculation (PE), using intravaginal ejaculatory latency time (IELT) and the self-report Premature Ejaculation Diagnostic Tool (PEDT) as primary outcomes. A total of 154 participants were retrospectively reviewed in this study, with 122 completing the training protocol. At baseline, all participants had an IELT ≤60 s and PEDT score >11. Participants completed a 12-week program of PFM rehabilitation, including physio-kinesiotherapy treatment, electrostimulation, and biofeedback, with three sessions per week, with 20 min for each component completed at each session. The effectiveness of intervention was evaluated by comparing the change in the geometric mean of IELT and PEDT values, from baseline, at 3, 6, and 12 months during the intervention, and at 24 and 36 months postintervention, using a paired sample 2-tailed t-test, including the associated 95% confidence intervals. Of the 122 participants who completed PFM rehabilitation, 111 gained control of their ejaculation reflex, with a mean IELT of 161.6 s and PEDT score of 2.3 at the 12-week endpoint of the intervention, representing an increase from baseline of 40.4 s and 17.0 scores, respectively, for IELT and PEDT (P < 0.0001). Of the 95 participants who completed the 36-month follow-up, 64% and 56% maintained satisfactory ejaculation control at 24 and 36 months postintervention, respectively.
Adolescent ; Adult ; Biofeedback, Psychology ; Electric Stimulation ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Muscle, Skeletal/physiology* ; Pelvic Floor Disorders/rehabilitation* ; Premature Ejaculation/rehabilitation* ; Reflex/physiology* ; Retrospective Studies ; Treatment Outcome ; Young Adult

ObjectiveTo evaluate the effect and safety of Yimusake Tablets combined with dapoxetine hydrochloride and either of them used alone in the treatment of premature ejaculation (PE).

METHODSWe randomly assigned 180 PE patients to oral medication of Yimusake Tablets at 1.5 g per night (group A), dapoxetine hydrochloride at 30 mg at 1－3 hours before anticipated sexual activity (group B), the Yimusake Tablets plus dapoxetine hydrochloride simultaneously (group C), all for 8 weeks. After 4 and 8 weeks of medication, we recorded and compared the changes in the intravaginal ejaculation latency time (IELT), measures of the PE profile (PEP), and adverse events among the three groups of patients.

RESULTSThe treatment was accomplished and complete data obtained from 154 of the patients, 56 in group A, 52 in group B, and 46 in group C. After 4 and 8 weeks of medication, the mean IELT was dramatically prolonged in all the three groups as compared with the baseline (P<0.01), most significantly at 8 weeks in group C (［2.08±0.68］ min), followed by B (［1.76±0.52］ min) and A (［1.47±0.44］ min), with statistically significant differences among the three groups (P<0.01). The PEP measures were remarkably improved in group A at 8 weeks (P<0.05), and both in B and C at 4 and 8 weeks (P<0.05), most significantly at 8 weeks in group C (P<0.05), in which the patients scored 1.96±0.77 in perception of control over ejaculation, 2.62±0.98 in satisfaction with sexual intercourse, 3.04±0.62 in PE-related distress, and 3.57±0.80 in PE-induced difficult relationship with their partners, all markedly improved as compared with groups A and B (P<0.05). Adverse reactions were observed in 2 cases (3.6%) in group A, 6 cases (9.6%) in B, and 5 cases (10.9%) in C. No severe adverse events occurred in any of the patients during the study.

CONCLUSIONSCombined medication of Yimusake Tablets and dapoxetine hydrochloride, with its advantages of effectiveness and safety, deserves to be recommended for the treatment of PE.

Administration, Oral ; Adult ; Benzylamines ; therapeutic use ; Coitus ; psychology ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Ejaculation ; Humans ; Male ; Naphthalenes ; therapeutic use ; Personal Satisfaction ; Premature Ejaculation ; drug therapy ; Sexual Behavior ; Tablets ; Time Factors ; Treatment Outcome

ObjectiveTo investigate the correlation between the premature ejaculation diagnostic tool (PEDT) and International Index of Erectile Function-15 (IIEF-15) in different types of premature ejaculation (PE).

METHODSWe performed a cross-section survey among 352 PE patients received in the andrology clinic from December 2014 to December 2015 and 104 healthy men from the health examination center using basic demographic information (as on age, height, weight, education status, occupation, income, etc.), PEDT results, and IIEF-15 scores of the subjects.

RESULTSThe PE patients had remarkably higher PEDT and lower IIEF-15 scores than the healthy men (P<0.01). The PEDT score of the PE patients was negatively correlated with their total IIEF-15 score as well as with the scores in the domains of erectile function, sexual intercourse satisfaction, and overall satisfaction after adjusted for age (P<0.01). The patients with acquired PE (APE) showed a lower IIEF-15 score than those with lifelong PE (LPE) (P<0.01). The PEDT score of the APE patients was correlated negatively with the total IIEF-15 score (r=－0.391, P<0.01) and the scores in the domains of erectile function (r=－0.362, P<0.01) and overall satisfaction (r=－0.621, P<0.01), but not correlated with intercourse satisfaction, sexual orgasm, or sexual desire. The PEDT score of the LPE group was correlated negatively with intercourse satisfaction (r=－0.286, P<0.05) but not correlated with either the total IIEF-15 score or the scores in the domains of erectile function, overall satisfaction, sexual orgasm, or sexual desire.

CONCLUSIONSPE patients have a higher PEDT score and a lower IIEF-15 score than normal males. The PEDT score of APE patients is significantly correlated with the total IIEF-15 score, while that of LPE patients is correlated not with the total IIEF-15 score but with intercourse satisfaction.

Adult ; Andrology ; Case-Control Studies ; Coitus ; psychology ; Cross-Sectional Studies ; Erectile Dysfunction ; physiopathology ; Humans ; Libido ; Male ; Middle Aged ; Penile Erection ; physiology ; Personal Satisfaction ; Premature Ejaculation ; diagnosis ; physiopathology ; Surveys and Questionnaires

OBJECTIVETo explore the clinical effect of Shugan Jieyu Capsules (SJC) on type III B prostatitis complicated by sexual dysfunction.

METHODSA total of 98 patients with type III B prostatitis complicated by sexual dysfunction were equally randomized to a control and a trial group, the former treated with the combination of biofeedback/electrical stimulation and the α-blocker Tamsulosin Hydrochloride, and the latter with oral SJC in addition, both for 8 weeks. Before and after treatment, the severity of the symptoms was determined with NIH-CPSI, the patients'sexual function evaluated with CIPE-5 and IIEF-5, and their anxiety, depression and other psychological problems assessed with Hamilton Anxiety Scale (HAMA) and Hamilton Depression Rating Scale ( HAMD). The results were subjected to statistical analysis and compared between the two groups.

RESULTSStatistically significant differences were found between the control and trial groups in the NIH-CPSI score (26.31 ± 7.91 vs 18.84 ± 6.63, P < 0.01), CIPE-5 premature ejaculation score (10. 41 ± 3.03 vs 14.37 ± 2.35, P < 0.05), IIEF-5 score (10.29 ± 3.97 vs 14.69 ± 4.19, P < 0.05), HAMA score (24.31 ± 1.78 vs 13.41 ± 4.21, P < 0.01), and HAMD score (25.24 ± 2.83 vs 14.49 ± 4.44, P < 0.01).

CONCLUSIONSJC can effectively relieve anxiety, depression and other psychological problems in type III B prostatitis patients with sexual dysfunction and improve their clinical symptoms as well.

Adrenergic alpha-1 Receptor Antagonists ; therapeutic use ; Adrenergic alpha-Antagonists ; Anxiety ; drug therapy ; Biofeedback, Psychology ; Capsules ; Depression ; diagnosis ; drug therapy ; Drugs, Chinese Herbal ; therapeutic use ; Electric Stimulation Therapy ; Humans ; Male ; Premature Ejaculation ; drug therapy ; etiology ; Prostatitis ; complications ; drug therapy ; Sulfonamides ; therapeutic use

On psychological aspect, premature ejaculation in psychosexual dysfunction is generally associated with anxiety. Psychiatrists consider that the treatment of choice for premature ejaculation is directive sextherapy with psychotherapy. We screened psychopathology according to the Symptom Checklist-90-Revision (SCL-90-R) in premature ejaculation group (n=120) and control group (n=92). The rate of abnormal RESULTS of both groups were similar as 5 (4.1%) in patient group and 4 (4.3%) in control group. And there was statistical significance in T scores on 5 symptom dimensions of Obsessive-Compulsive, Interpersonal Sensitivity, Depression, Anxiety and Psychoticism, but all of the T scores of those dimensions were with in the normal range. The psychological personality test does not reflect all of the psychosexual factors. But with the psychological screening, we could find that the psychological factors are not absolutely associated with premature ejaculation.
Anxiety ; Depression ; Humans ; Mass Screening ; Personality Tests* ; Premature Ejaculation* ; Psychiatry ; Psychology ; Psychopathology ; Psychotherapy ; Reference Values ; Sexual Dysfunctions, Psychological